InvestorsHub Logo
Followers 2431
Posts 91152
Boards Moderated 8
Alias Born 09/12/2003

Re: None

Tuesday, 05/19/2020 12:50:14 PM

Tuesday, May 19, 2020 12:50:14 PM

Post# of 35961
LICENSING DEAL OR NOT?... ONE CAN'T REFUSES TO ADMIT THE TRUTH EXISTENCE OF MISAGARGIN USED IN A NEW PATENT FOR THE TREATMENT OF GLOBALASTOMA.

MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma

https://www.biospace.com/article/releases/medicinova-receives-notice-of-allowance-for-second-patent-covering-mn-166-ibudilast-for-the-treatment-of-glioblastoma/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News